Loading organizations...
Buttonwood Network provides a software platform built to optimize capital raising for high-growth, late-stage startups. The platform enhances the efficiency of securing significant equity funding rounds, specifically targeting Series B, C, D, or pre-IPO stages. It offers tools for businesses seeking over $10 million in equity to manage and accelerate their fundraising efforts.
Founded by Marcello Halitzer around 2019, Buttonwood Network emerged from the insight that later-stage fundraising often lacked the streamlined processes of earlier rounds. Halitzer identified this market inefficiency, aiming to simplify and improve the experience for both startups and investors pursuing growth capital.
Buttonwood Network primarily serves elite, growth-stage startups seeking considerable equity capital and investors in these large funding rounds. The platform enables businesses to create comprehensive profiles for investment pitches, fostering organized communication. Its vision is to standardize and democratize access to growth capital, creating a faster, more transparent, and efficient fundraising ecosystem.
Buttonwood has 1 tracked investment across 1 company. The latest tracked deal is $39.0M Series D in Rani Therapeutics in September 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2017 | Rani Therapeutics | $39.0M Series D | — | Byers Capital, Founders' Co OP, Seven Seven SIX, Susa Ventures, Y Combinator, Justin Mateen, AstraZeneca, Bossanova Investimentos, Cathay Innovation, Crystal Horizon Investments, GV, Novartis, Pacific Venture Opportunity Fund, Pinemount Investments |